Growing Spending In R&D Activities Expected To Fuel Global Parkinson’s Disease Drug Market Growth
A progressive, degenerative neurological motor disorder, Parkinson’s disease mainly impacts the brain’s dopaminergic cells. The signs of this disorder comprise tremor, rigidity, postural instability, and bradykinesia. In the recent years, growth has been observed within the global Parkinson’s disease drug market due to a huge patient pool along with the elevated rate of diagnosis. In addition, the rising incidence of Parkinson’s disease and the growing spending in R&D activities are